Videos (ISHL12)

Patient perspective

Seminar Living beyond Lymphoma Patient perspective

Louise Jennings, Jack Richardson


Introduction to GHSG

Joint EHA-ISHL Symposium Introduction to GHSG

Peter Borchmann


MTV and Baseline PET biomarkers

Workshop PET beyond Deauville MTV and Baseline PET biomarkers

Sally Barrington


Lymphoma Biology and Immunosenescence in Older Patients

Workshop Innovation for Older Patients Lymphoma Biology and Immunosenescence in Older Patients

Alessandra Tucci


Organisation of HL survivorship care in the UK, ADAPT program

Seminar Living beyond Lymphoma Organisation of HL survivorship care in the UK, ADAPT program

John Radford, Tracy Howe



In memoriam of Ton Hagenbeek

Joint EHA-ISHL Symposium In memoriam of Ton Hagenbeek

Marie Jose Kersten


Latest developments in software and PET technology

Workshop PET beyond Deauville Latest developments in software and PET technology

Irene Buvat, Carsten Kobe


Efficacy and Safety of Targeted Drugs in Older HL Patients

Workshop Innovation for Older Patients Efficacy and Safety of Targeted Drugs in Older HL Patients

Ingrid Glimelius



Microenvironmental Lessons from the NIVAHL Trial

Workshop The HL Microenvironment Microenvironmental Lessons from the NIVAHL Trial

Wolfram Klapper


Future perspectives for prognostication and MRD in cHL

Joint EHA-ISHL Symposium Future perspectives for prognostication and MRD in cHL

Sven Borchmann


Imaging response in the context of immunotherapy

Workshop PET beyond Deauville Imaging response in the context of immunotherapy

Philippe Armand, Martin Hutchings


Current and Future Trial Landscape in Older Patients

Workshop Innovation for Older Patients Current and Future Trial Landscape in Older Patients

Alexander Fosså


Organisation of HL survivorship care in the U.S.

Seminar Living beyond Lymphoma Organisation of HL survivorship care in the U.S.

Kevin Oeffinger


EV miRNA in cHL

Joint EHA-ISHL Symposium EV miRNA in cHL

Michiel Pegtel


Open Discussion Forum: Adressing Unmet Needs

Workshop Innovation for Older Patients Open Discussion Forum: Adressing Unmet Needs



Framing the discussion and key issues in adolescent and young adult Hodgkin Lymphoma

Seminar Learning from Pediatric HL Framing the discussion and key issues in adolescent and young adult Hodgkin Lymphoma

Christine Mauz-Körholz


Liquid Biopsy in Lymphoma: The Swiss Experience

Workshop Bringing Liquid Biopsy to Patients Liquid Biopsy in Lymphoma: The Swiss Experience

Cristina Pirosa


Where belongs NLPHL? Biology and pathology

Workshop NLPHL Where belongs NLPHL? Biology and pathology

Sylvia Hartmann


Who benefits from adding radiotherapy even if PET-negative based on the RAPID study data

Seminar Radiotherapy: Identifying the Beneficiaries Who benefits from adding radiotherapy even if PET-negative based on the RAPID study data

David Cutter



Liquid Biopsy in Lymphoma: The Cologne experience

Workshop Bringing Liquid Biopsy to Patients Liquid Biopsy in Lymphoma: The Cologne experience

Michel Heger


Treatment of NLPHL: what evidence is available?

Workshop NLPHL Treatment of NLPHL: what evidence is available?

Dennis Eichenauer


The experience of incorporating RT into CAR-T cell salvage programs- Does it apply to HL patients?

Seminar Radiotherapy: Identifying the Beneficiaries The experience of incorporating RT into CAR-T cell salvage programs- Does it apply to HL patients?

Brandon Imber


SEARCH for CAYAHL initiative

Seminar Learning from Pediatric HL SEARCH for CAYAHL initiative

Jamie Flerlage


Integrating Fragmentomics and MRD in Lymphoma

Workshop Bringing Liquid Biopsy to Patients Integrating Fragmentomics and MRD in Lymphoma

Leo Meriranta



Importance of QoL and PROs in long-term follow-up of HL

Seminar Learning from Pediatric HL Importance of QoL and PROs in long-term follow-up of HL

Susan Parsons


Challenges in bringing Liquid Biopsy to Lymphoma patients – Kick-off talk for round table

Workshop Bringing Liquid Biopsy to Patients Challenges in bringing Liquid Biopsy to Lymphoma patients – Kick-off talk for round table

Sven Borchmann



Lessons from European Network for Pediatric Hodgkin Lymphoma

Seminar Learning from Pediatric HL Lessons from European Network for Pediatric Hodgkin Lymphoma

Dieter Körholz


In memoriam of Saul Rosenberg

Satellite Symposium Opening paths to the next chapters of lymphoma treatmen In memoriam of Saul Rosenberg

Ranjana Advani


Welcome and Introduction to the topic

Satellite Symposium Opening paths to the next chapters of lymphoma treatmen Welcome and Introduction to the topic

Peter Borchmann


Hodgkin’s lymphoma as a model for immuno-oncologic therapeutic approaches to lymphoma

Satellite Symposium Opening paths to the next chapters of lymphoma treatmen Hodgkin’s lymphoma as a model for immuno-oncologic therapeutic approaches to lymphoma

Paul J. Bröckelmann


The challenge of the older patient in lymphoma therapy

Satellite Symposium Opening paths to the next chapters of lymphoma treatmen The challenge of the older patient in lymphoma therapy

Graham Collins


New trends in lymphoma therapy: future role of BTKi / CAR-T / bispecific antibodies

Satellite Symposium Opening paths to the next chapters of lymphoma treatmen New trends in lymphoma therapy: future role of BTKi / CAR-T / bispecific antibodies

Pier Luigi Zinzani


Standard treatment of early-stage HL

Scientific Session Early Stages Standard treatment of early-stage HL

John Radford


Individual risk assessment of RT in HL

Scientific Session Early Stages Individual risk assessment of RT in HL

Richard Hoppe


WS Report: NLPHL

Scientific Session Early Stages WS Report: NLPHL

Dennis Eichenauer, Michael Binkley, Sylvia Hartmann





Status quo of CAR T cell therapy for r/r DLBCL

Satellite Symposium CAR T cell therapy in B Cell NHL: Status quo and future perspectives Status quo of CAR T cell therapy for r/r DLBCL

Peter Borchmann


New perspective for the treatment of r/r CLL

Satellite Symposium CAR T cell therapy in B Cell NHL: Status quo and future perspectives New perspective for the treatment of r/r CLL

Paula Cramer


CAR T – Lessons Learned

Satellite Symposium CAR T cell therapy in B Cell NHL: Status quo and future perspectives CAR T – Lessons Learned

Christoph Scheid


Welcoming Address

Main Program Opening and Award Ceremony Welcoming Address

Andreas Engert


Award Ceremony

Main Program Opening and Award Ceremony Award Ceremony

Sven Borchmann, Peter Borchmann, Paul J. Bröckelmann, Dennis Eichenauer


Introduction to the Keynote Lecturer

Main Program Opening and Award Ceremony Introduction to the Keynote Lecturer

Volker Diehl


Keynote Lecture

Main Program Opening and Award Ceremony Keynote Lecture

Uğur Şahin


Case presentation: Greyzone Lymphoma

Scientific Session Interactive Case Discussion Case presentation: Greyzone Lymphoma

László Imre Pinczés


Case presentation: Anti-PD1 Failure

Scientific Session Interactive Case Discussion Case presentation: Anti-PD1 Failure

Graham Collins


Case presentation: COVID19 immunity in lymphoma

Scientific Session Interactive Case Discussion Case presentation: COVID19 immunity in lymphoma

Sybille Mellinghoff


Case presentation: Primary progressive HL

Scientific Session Interactive Case Discussion Case presentation: Primary progressive HL

Anne Sophie Jacob


Clinical experience with  Cellular Therapy in cH

Scientific Session Emerging Cellular Therapies – a Role in HL? Clinical experience with Cellular Therapy in cH

Barbara Savoldo


Design and manufacturing of CD30 CARs for cHL

Scientific Session Emerging Cellular Therapies – a Role in HL? Design and manufacturing of CD30 CARs for cHL

Concetta Quintarelli


Emerging indications for cellular therapy

Scientific Session Emerging Cellular Therapies – a Role in HL? Emerging indications for cellular therapy

Peter Borchmann


Towards Lung Cancer Screening in Hodgkin Lymphoma Survivors

Scientific Session Living beyond Lymphoma Towards Lung Cancer Screening in Hodgkin Lymphoma Survivors

Kim Linton


GHSG data on fertility, fatigue and social reintegration and the ongoing EMBrACe study

Scientific Session Living beyond Lymphoma GHSG data on fertility, fatigue and social reintegration and the ongoing EMBrACe study

Karolin Behringer


WS Report: Living beyond Lymphoma

Scientific Session Living beyond Lymphoma WS Report: Living beyond Lymphoma

Flora van Leeuwen, Lena Specht


Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors

Scientific Session Living beyond Lymphoma Doxorubicin exposure and breast cancer risk in adolescent and adult Hodgkin lymphoma survivors

Suzanne Neppelenbroek




Firstline therapy of classical Hodgkin Lymphoma – How can immunotherapy improve outcome?

Satellite Symposium Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives Firstline therapy of classical Hodgkin Lymphoma – How can immunotherapy improve outcome?

Peter Borchmann


The current role of PD-1 inhibition in the treatment of relapsed or refractory classical Hodgkin Lymphoma

Satellite Symposium Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives The current role of PD-1 inhibition in the treatment of relapsed or refractory classical Hodgkin Lymphoma

Bastian von Tresckow


Strategies to enhance checkpoint inhibition

Satellite Symposium Checkpoint Inhibition in Hodgkin Lymphoma – State of the art and future perspectives Strategies to enhance checkpoint inhibition

Paul J. Bröckelmann


Managing an Older Lymphoma Patient

Scientific Session Older and Frail Patients Managing an Older Lymphoma Patient

Raul Cordoba Mascuñano


Treatment Strategies in Older HL Patients

Scientific Session Older and Frail Patients Treatment Strategies in Older HL Patients

Andrew Evens


Workshop Report: Innovation for Older patients

Scientific Session Older and Frail Patients Workshop Report: Innovation for Older patients

Alexander Fosså, Paul J. Bröckelmann





Welcome and introduction

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Welcome and introduction

Anna Sureda


Navigating Complex Treatment Decisions in R/R HL

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Navigating Complex Treatment Decisions in R/R HL

Theodoros Vasilakopoulos


Challenging Case Study #1

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Challenging Case Study #1

Martin Hutchings


Learning from Real-World Evidence to Inform Treatment Decisions in R / R HL

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Learning from Real-World Evidence to Inform Treatment Decisions in R / R HL

Anna Sureda


Challenging Case Study #2

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Challenging Case Study #2

Martin Hutchings


Audience Q&A

Satellite Symposium Unraveling Complex Treatment Pathways for Patients with Relapsed / Refractory Hodgkin Lymphoma Audience Q&A


Vision Corner Stimulus Talk: The future of translational science in HL

Scientific Session Immunotherapy Vision Corner Stimulus Talk: The future of translational science in HL

Christian Steidl



Vision Corner Stimulus Talk: Leveraging PD1 blockade for cure

Scientific Session Immunotherapy Vision Corner Stimulus Talk: Leveraging PD1 blockade for cure

Paul J. Bröckelmann


Vision Corner: Discussion

Scientific Session Immunotherapy Vision Corner: Discussion

Paul J. Bröckelmann, Graham Collins, Christian Steidl


New findings and new challenges since last ISHL

Scientific Session Immunotherapy New findings and new challenges since last ISHL

Stephen Ansell




Why I recommend BV-AVD

Scientific Session Advanced Stages Why I recommend BV-AVD

Ranjana Advani


Why I recommend PET-guided ABVD

Scientific Session Advanced Stages Why I recommend PET-guided ABVD

Alexander Fosså


Why I recommend PET-adapted escalated BEACOPP

Scientific Session Advanced Stages Why I recommend PET-adapted escalated BEACOPP

Peter Borchmann


Discussion forum: Challenging standard recommendations from a patient's, nurse's and physician's perspective

Scientific Session Advanced Stages Discussion forum: Challenging standard recommendations from a patient's, nurse's and physician's perspective

Martin Dreyling, Sarah Wells, Jack Richardson


WS Report: Learning through International Collaboration

Scientific Session Advanced Stages WS Report: Learning through International Collaboration

Peter Borchmann, Alison Moskowitz




HL in Pregnancy

Scientific Session Special Situations in HL HL in Pregnancy

Daan Dierickx


HIV-positive HL

Scientific Session Special Situations in HL HIV-positive HL

Otavio Baiocchi


alloSCT in the era of anti-PD1

Scientific Session Special Situations in HL alloSCT in the era of anti-PD1

Anna Sureda


Biological Classification of HL by Liquid Biopsy

Scientific Session Genomics, Biology and Microenvironment Biological Classification of HL by Liquid Biopsy

Sven Borchmann


Single Cell Transcriptomics of HL

Scientific Session Genomics, Biology and Microenvironment Single Cell Transcriptomics of HL

Christian Steidl


WS Report:  Bringing Liquid Biopsy to Patients

Scientific Session Genomics, Biology and Microenvironment WS Report: Bringing Liquid Biopsy to Patients

Sven Borchmann, Davide Rossi


Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma

Scientific Session Genomics, Biology and Microenvironment Characterization of cancer-associated fibroblasts in classical Hodgkin lymphoma

Kristiina Karihtala




Welcome and introduction

Satellite Symposium Bridging the gap between efficacy and toxicity in the frontline treatment of stage IV Hodgkin lymphoma Welcome and introduction

Graham Collins


Hot off the press: The latest data for the frontline treatment of patients with Stage IV CD30+ Hodgkin Lymphoma from ECHELON-1

Satellite Symposium Bridging the gap between efficacy and toxicity in the frontline treatment of stage IV Hodgkin lymphoma Hot off the press: The latest data for the frontline treatment of patients with Stage IV CD30+ Hodgkin Lymphoma from ECHELON-1

Graham Collins


Bridging the gap: Balancing efficacy and toxicity in three challenging case studies (A debate and audience discussion with our panel)

Satellite Symposium Bridging the gap between efficacy and toxicity in the frontline treatment of stage IV Hodgkin lymphoma Bridging the gap: Balancing efficacy and toxicity in three challenging case studies (A debate and audience discussion with our panel)

Alex Herrera, Graham Collins, Pier Luigi Zinzani


Audience Q&A

Satellite Symposium Bridging the gap between efficacy and toxicity in the frontline treatment of stage IV Hodgkin lymphoma Audience Q&A


1ˢᵗ Relapse of HL

Scientific Session Relapsed / Refractory HL 1ˢᵗ Relapse of HL

Craig H. Moskowitz


Novel developments in R/R HL

Scientific Session Relapsed / Refractory HL Novel developments in R/R HL

Graham Collins


WS Report: PET beyond Deauville

Scientific Session Relapsed / Refractory HL WS Report: PET beyond Deauville

Sally Barrington, Martin Hutchings, Carsten Kobe





Conference Highlights

Main Program Closing Remarks Conference Highlights

Ranjana Advani


ISHL12 Videos

To watch the recorded talks please log in using the same credentials that were sent to you during the conference for watching the live stream.

If you are registered for the conference but did not receive your credentials please contact info@hodgkinsymposium.org.